The Pharmaceris brand, owned by Dr Irena Eris, will go to pharmacies in another five countries: Israel, Jordan, Croatia, Romania and Portugal, the company said. “Pharmaceris dermocosmetics and medical devices have been present on the market for 24 years, and Emotopic for 8 years. During this time, they have gained the trust of customers. Currently, our sales of this product category account for approximately 40% of the cosmetics segment's revenues. Dermocosmetics is a rapidly growing and high-margin market segment in which we want to further strengthen our position through further development of our product offer and new markets. Other brands from the Dr Irena Eris S.A. portfolio are already present in four of the five markets where we are currently introducing our products. Israel is a completely new market for our group. We assume that more brands will soon join Pharmaceris in this country, ”said Paweł Orfinger, president of Dr Irena Eris, quoted in the press release. In 2021, the Dr Irena Eris Group achieved a total of PLN 297.6 million in sales revenues in its two business segments - the cosmetics and hotel segment. In the discussed period, the cosmetics segment generated 80.9% of revenues (PLN 240.6 million), and the hotel segment generated 19.1% (PLN 57 million). In 2021, product exports accounted for 32% of the cosmetics segment's revenues in 2021. The Dr Irena Eris Group is one of the leading Polish cosmetics producers and the owner of the following brands: Dr Irena Eris, Pharmaceris, Emotopic, Lirene and Under Twenty. The company also operates a chain of three hotels under the Dr Irena Eris SPA Hotels brand in Krynica-Zdrój (Małopolska), Wzgórze Dylewskie (Western Masuria) and in Polanica-Zdrój (Kotlina Kłodzka). Established in 1983, the company has been developing as a family business for nearly 40 years. Source
10.06.2022